Compare RGEN & HXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGEN | HXL |
|---|---|---|
| Founded | 1981 | 1946 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 6.8B |
| IPO Year | 1995 | 1994 |
| Metric | RGEN | HXL |
|---|---|---|
| Price | $124.05 | $90.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 10 |
| Target Price | ★ $167.67 | $88.30 |
| AVG Volume (30 Days) | ★ 1.3M | 826.3K |
| Earning Date | 05-05-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 0.80% |
| EPS Growth | ★ 286.96 | N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $141,236,000.00 | ★ $1,893,900,000.00 |
| Revenue This Year | $14.30 | $10.09 |
| Revenue Next Year | $14.52 | $12.33 |
| P/E Ratio | $824.80 | ★ N/A |
| Revenue Growth | ★ 35.10 | N/A |
| 52 Week Low | $100.99 | $51.94 |
| 52 Week High | $175.77 | $98.26 |
| Indicator | RGEN | HXL |
|---|---|---|
| Relative Strength Index (RSI) | 59.18 | 51.36 |
| Support Level | $121.25 | $88.83 |
| Resistance Level | $129.77 | $95.94 |
| Average True Range (ATR) | 6.49 | 3.09 |
| MACD | 1.57 | -0.35 |
| Stochastic Oscillator | 88.42 | 57.12 |
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.
Founded in 1948, Hexcel designs and manufactures a range of highly engineered composite fibers, fabrics, resins, and structures for use primarily in the commercial aerospace and defense markets. These are lighter than metal and perform under rigorous conditions in aircraft frames, wings, engine nacelles, and other structures and subassemblies. The company's name derives from the six-sided honeycomb structures that lend many of its products their light weight and rigidity. Hexcel's biggest customers are Airbus (40% of 2024 sales) and Boeing (15% of 2024 sales; 25% before the pandemic) and their respective subcontractors.